护卫决定:目前的证据和癌的淋巴结评估的最佳实践
Malavika Perinchery1, Kathryn Mills2
1University of Chicago Medical Center, Department of Obstetrics and Gynecology, United States.
Gynecologic oncology reports
|September 2, 2025
概括
护卫淋巴结解剖 (SLND) 提供了一种不那么侵入性的手术瘤方法,减少了和感染等并发症. 本综述探讨了关于阴道和宫癌的SLND最佳实践.
科学领域:
- 外科瘤学
- 妇科瘤学
背景情况:
- 护卫淋巴结解剖已经改变了手术瘤学.
- 与完整的淋巴切除术相比,SLND提供了好处,包括减少下肢胀,感染率和血液损失.
- 在癌和子宫癌中使用SLNB已得到充分证实.
研究的目的:
- 审查目前的临床临床临床临床临床临床临床临床临床临床
- 突出SLND作为选择性阴道癌和子宫癌患者的完全淋巴切除术的替代方案的有效性.
主要方法:
- 在部和子宫癌中对哨戒淋巴结活检 (SLNB) 的文献综述.
- 分析与不同的绘图技术和染料相关的结果,例如印ocyanine Green (ICG).
主要成果:
- 在部和子宫癌治疗中,SLNB是完整淋巴切除术的可行替代方案.
- 使用ICG等特定染料带来了积极的结果和实践变化.
结论:
- 护卫淋巴结解剖是妇科癌症外科瘤学的关键进展.
- 目前的证据支持SLND作为一种安全有效的方法来分辨阴道癌和子宫癌,技术和材料的不断改进.
相关概念视频
Targeted Cancer Therapies
7.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.1K
Cancer Survival Analysis
870
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
870


